Projects per year
Personal profile
Headline
Biography
Fingerprint
- 1 Similar Profiles
Network
Projects
- 8 Finished
-
DYSLIPIDEMIA IN CHRONIC KIDNEY DISEASE
National Center for Research Resources
1/03/09 → 31/07/09
Project: Research
-
CHRONIC KIDNEY DISEASE IN CHILDREN STUDY
National Center for Research Resources
1/03/09 → 31/07/09
Project: Research
-
DYSLIPIDEMIA IN CHRONIC KIDNEY DISEASE
National Center for Research Resources
1/03/07 → 29/02/08
Project: Research
-
CHRONIC KIDNEY DISEASE IN CHILDREN STUDY
National Center for Research Resources
1/03/07 → 29/02/08
Project: Research
-
A PROSPECTIVE DATABASE OF INFANTS WITH CHOLESTASIS
National Center for Research Resources
1/03/07 → 29/02/08
Project: Research
-
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1
Hulton, S. A., Groothoff, J. W., Frishberg, Y., Koren, M. J., Overcash, J. S., Sellier-Leclerc, A. L., Shasha-Lavsky, H., Saland, J. M., Hayes, W., Magen, D., Moochhala, S. H., Coenen, M., Simkova, E., Garrelfs, S. F., Sas, D. J., Meliambro, K. A., Ngo, T., Sweetser, M. T., Habtemariam, B. A., Gansner, J. M., & 2 others , Mar 2022, In: Kidney International Reports. 7, 3, p. 494-506 13 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study
CKiD Study Investigators, Aug 2022, In: American Journal of Kidney Diseases. 80, 2, p. 174-185.e1Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring
Lozano, R., Gbekie, C., Siper, P. M., Srivastava, S., Saland, J. M., Sethuram, S., Tang, L., Drapeau, E., Frank, Y., Buxbaum, J. D. & Kolevzon, A., Dec 2021, In: Journal of Neurodevelopmental Disorders. 13, 1, 18.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
Lumasiran, an RNAi therapeutic for primary hyperoxaluria type 1
Garrelfs, S. F., Frishberg, Y., Hulton, S. A., Koren, M. J., O’Riordan, W. D., Cochat, P., Deschênes, G., Shasha-Lavsky, H., Saland, J. M., van’t Hoff, W. G., Fuster, D. G., Magen, D., Moochhala, S. H., Schalk, G., Simkova, E., Groothoff, J. W., Sas, D. J., Meliambro, K. A., Lu, J., Sweetser, M. T., & 5 others , 1 Apr 2021, In: New England Journal of Medicine. 384, 13, p. 1216-1226 11 p.Research output: Contribution to journal › Article › peer-review
Open Access128 Scopus citations -
Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function
Gruber, C. N., Calis, J. J. A., Buta, S., Evrony, G., Martin, J. C., Uhl, S. A., Caron, R., Jarchin, L., Dunkin, D., Phelps, R., Webb, B. D., Saland, J. M., Merad, M., Orange, J. S., Mace, E. M., Rosenberg, B. R., Gelb, B. D. & Bogunovic, D., 15 Sep 2020, In: Immunity. 53, 3, p. 672-684.e11Research output: Contribution to journal › Article › peer-review
Open Access33 Scopus citations
Press / Media
-
Alnylam Releases Positive Early Results on Clinical Outcome Measures from ILLuminate-A Phase 3 Study of OXLUMO
6/05/21
1 item of Media coverage
Press/Media
-
Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO (lumasiran)
3/05/21 → 5/05/21
2 items of Media coverage
Press/Media
-
-Alnylam Announces Positive Early Results on Clinical Outcome Measures from ILLUMINATE-A Phase 3 Study of OXLUMO (lumasiran)
4/05/21
1 item of Media coverage
Press/Media
-
US FDA approves Alnylam's Oxlumo to treat primary hyperoxaluria type 1 to lower urinary oxalate levels in pediatric and adult patients
26/11/20
1 item of Media coverage
Press/Media